DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Jazz Pharmaceuticals plc (JAZZ)
« Back to company indexJAZZ Chatter Timeline
Stock Ticker for JAZZ
Most Active Tweeters for JAZZ
| User | Tweets |
|---|---|
| @Jdalexander64 | 13 |
| @ChartMill | 10 |
| @SeasonalEdge | 4 |
| @AmericanBanking | 3 |
| @Gambiste1 | 3 |
Recent Tweets for JAZZ
 |
@AmericanBanking Jazz Pharmaceuticals’ $JAZZ “Buy” Rating Reiterated at Wells Fargo & Co https://t.co/x4MeG4upZh #stocks June 17th 2019, 4:06pm |
 |
@Briefingcom $JAZZ: Jazz Pharma announces that the DEA has designated solriamfetol (Sunosi) as a Schedule IV medicine https://t.co/Ll67WWP6X9 June 17th 2019, 10:06am |
 |
@TickerReport Jazz Pharmaceuticals $JAZZ Lowered to Strong Sell at BidaskClub https://t.co/Sf1XBbuSOl June 15th 2019, 4:06am |
 |
@1MinuteStock We calculated 63-day Expected Return of $JAZZ for you: -2.37% https://t.co/C2HiXMuiZ5 June 14th 2019, 6:06pm |
 |
@fintel_io $JAZZ / Jazz Pharmaceuticals files form DEF 14A https://t.co/EMsMBB354R June 14th 2019, 4:06pm |
 |
@Stock_News_Now $JAZZ: New SEC Filing for JAZZ: Form DEFA14A (No. 0001193125-19-173664): https://t.co/GUXp5jsGHf June 14th 2019, 4:06pm |
 |
@StockTexts $JAZZ Jazz Pharmaceuticals plc SEC Filing: Form DEF 14A https://t.co/FIQxmMDm0Y June 14th 2019, 4:06pm |
 |
@ExecPayOrg Jazz Pharmaceuticals CEO Bruce Cozadd's 2018 pay rises 11% to $11.4M https://t.co/hwCrJNuyGb $JAZZ #execpay June 14th 2019, 4:06pm |
 |
@ProVesting $WEX $JAZZ: Here’s What Hedge Funds Think About WEX Inc (WEX): https://t.co/8I3VMLWKHi June 14th 2019, 3:06pm |
 |
@CristinNara $jazz and $sage get expected DEA scheduling. more on @TheTerminal June 14th 2019, 9:06am |
 |
@chaffeybreeze Barclays Begins Coverage on Jazz Pharmaceuticals $JAZZ https://t.co/M13zcoFE8c #stocks June 14th 2019, 5:06am |
 |
@IRAMarketReport Barclays Begins Coverage on Jazz Pharmaceuticals $JAZZ https://t.co/QtN7zdusGz #markets June 14th 2019, 5:06am |
 |
@WeekHerald Jazz Pharmaceuticals $JAZZ Rating Lowered to Strong Sell at BidaskClub https://t.co/2o5RctW3Nj June 13th 2019, 1:06pm |
 |
@Jdalexander64 @SolarMelt That 1x-nightly Xyrem would be a very big deal to $JAZZ especially if patent claims hold that 7.5g is eq… https://t.co/zBZGGehfbZ June 13th 2019, 8:06am |
 |
@ThisLincolnian Jazz Pharmaceuticals $JAZZ Receives New Coverage from Analysts at Barclays https://t.co/CRFEzcnN9e June 13th 2019, 5:06am |
 |
@ChartMill $JAZZ showing up in our top Decent Value selection. https://t.co/dwI80ZGLLF https://t.co/7GFai2J6uS June 13th 2019, 4:06am |
 |
@SeasonalEdge Today's insight on $JAZZ https://t.co/ID8aOeq7v8 https://t.co/okw2M2CBgE June 13th 2019, 4:06am |
|
@ChartMill $JAZZ has an attractive valuation and strong overall fundamentals. https://t.co/dwI80ZGLLF https://t.co/Igi5t3TE3q June 12th 2019, 4:06am |
|
@ChartMill $JAZZ showing up in our top Decent Value selection. https://t.co/sHE6DIwcFy https://t.co/YEWRHYC8aO June 11th 2019, 9:06am |
 |
@firsttomarkets Jazz Pharmaceuticals PLC Initiated Coverage by Barclays Capital (Ranked 33rd) to Overweight with $164PT $JAZZ #JAZZ https://t.co/7exlBIydjC June 11th 2019, 8:06am |
|
@SeasonalEdge Today's insight on $JAZZ https://t.co/ID8aOeq7v8 https://t.co/4aMs8c2a2n June 11th 2019, 8:06am |
|
@SeasonalEdge Daily trading range of $JAZZ https://t.co/JpYhU07e7I https://t.co/Mqy5jZlgBJ June 11th 2019, 8:06am |
|
@AmericanBanking Jazz Pharmaceuticals $JAZZ Now Covered by Analysts at Barclays https://t.co/hefyxLZ1N3 #stocks June 11th 2019, 8:06am |
 |
@dispatchtribune Jazz Pharmaceuticals $JAZZ Receives New Coverage from Analysts at Barclays https://t.co/Q8ezBEvuQS June 11th 2019, 7:06am |
 |
@JUSTUSnatuhwera RT @Briefingcom: $JAZZ: Barclays starts at Overweight https://t.co/ZrZeUCC3H7 June 11th 2019, 7:06am |
|
@Briefingcom $JAZZ: Barclays starts at Overweight https://t.co/ZrZeUCC3H7 June 11th 2019, 7:06am |
 |
@AnalystWire Barclays Starts Jazz Pharmaceuticals $JAZZ at Overweight https://t.co/CINKxeI0Wf June 11th 2019, 2:06am |
 |
@TranscriptDaily Jazz Pharmaceuticals PLC $JAZZ Expected to Post Earnings of $3.59 Per Share https://t.co/Tzw7wrsBKV June 10th 2019, 11:06pm |
 |
@Gambiste1 RT @Jdalexander64: @semodough $JAZZ will leave firepower for $AVDL FT-218 as its mimicking of Xyrem PK but w/ several big advantages (lower… June 10th 2019, 4:06pm |
|
@Jdalexander64 @Abby10Smalls @semodough Probably what $JAZZ means about "evaluating transactions in sleep." $AVDL must be on top… https://t.co/MV85bZl2WK June 10th 2019, 4:06pm |
|
@Jdalexander64 @semodough $JAZZ will leave firepower for $AVDL FT-218 as its mimicking of Xyrem PK but w/ several big advantages (… https://t.co/s9xVD5jk84 June 10th 2019, 4:06pm |
 |
@RobinDavison2 RT @semodough: $JAZZ mgmt emphasized biz dev is still a priority for Jazz to sustain long-term growth. Jazz is evaluating potential transac… June 10th 2019, 4:06pm |
 |
@semodough $JAZZ mgmt emphasized biz dev is still a priority for Jazz to sustain long-term growth. Jazz is evaluating potentia… https://t.co/0vFzSivTbT June 10th 2019, 3:06pm |
|
@Jdalexander64 @McBurnMark $AVDL has cash thru early 2021, enough for UMD PDUFA 9/19 & FT-218 data readout or $JAZZ buyout, whiche… https://t.co/EJLN3M7ujS June 10th 2019, 3:06pm |
|
@Jdalexander64 @AASMorg @NarcolepsyNtwrk $AVDL once-nightly sodium oxybate better than $JAZZ twice-nightly Xyrem extending REM sle… https://t.co/1Lkz13oUV2 June 10th 2019, 1:06pm |
|
@Jdalexander64 $AVDL FT-218 showed similar Actigraphy sleep time over 8 hours versus $JAZZ Xyrem & prototype #2 showed zero safety… https://t.co/mN47qsNRUg June 10th 2019, 10:06am |
|
@Jdalexander64 $AVDL FT-218 PK formulation selection #2 has AUC almost identical to $JAZZ 2x nightly Xyrem but with 30% lower Cmax… https://t.co/1HJJlrZIOA June 10th 2019, 10:06am |
|
@Jdalexander64 The risk-weighted probability value of FT-218 is $500 million, w/ very similar once-nightly PK data to $JAZZ 2x-nig… https://t.co/yEa9luF5gU June 10th 2019, 9:06am |
 |
@fda_tracker $JAZZ Phase 2 trial w/est Jun completion date NCT02806895: https://t.co/H9lJwK4OT4 Trial Tracker: https://t.co/aR7q5oJwjn June 10th 2019, 9:06am |
|
@Jdalexander64 $AVDL FT-218 Once-nightly PK comparison with twice-nightly $JAZZ Xyrem presented at SLEEP2019… https://t.co/0zYtc4LF0p June 10th 2019, 7:06am |
|
@Jdalexander64 RT @Abby10Smalls: $JAZZ booth 400 is just a stone's throw from $AVDL booth 1027 at #Sleep2019. Anyone going to San Antonio that can check… June 9th 2019, 1:06pm |
|
@Jdalexander64 @Abby10Smalls Also $AVDL is claiming lower-equivalent FT-218 to $JAZZ Xyrem dose looks like a better Xyrem dosed be… https://t.co/RSiTUlmn8W June 9th 2019, 9:06am |
|
@Jdalexander64 $AVDL FT-218 2 years & now 2/3 complete, should finish in 12 months $JAZZ can’t afford a readout because positive d… https://t.co/foLpuX5fQu June 9th 2019, 9:06am |
|
@SeasonalEdge Today's insight on $JAZZ https://t.co/ID8aOeq7v8 https://t.co/ItgeihNpZj June 9th 2019, 2:06am |
|
@ChartMill $JAZZ has an attractive valuation and strong overall fundamentals. https://t.co/dwI80ZGLLF https://t.co/fSzZssyeEx June 8th 2019, 3:06pm |
|
@WeekHerald Brokerages Expect Jazz Pharmaceuticals PLC $JAZZ Will Post Earnings of $3.59 Per Share https://t.co/OIInD9UTR9 June 8th 2019, 2:06pm |
|
@ChartMill $JAZZ has an attractive valuation and strong overall fundamentals. https://t.co/sHE6DIwcFy https://t.co/DxX9V3Ijcp June 8th 2019, 8:06am |
 |
@InsiderAlertsIA $JAZZ: New Insider Filing on EVP, US Commercial MICHAEL PATRICK MILLER: https://t.co/RSur6HI7Q1 June 7th 2019, 4:06pm |
 |
@tradnews_ RT @AlertTrade: TREND REVERSAL UP ALERT: $JAZZ Jazz Pharmaceuticals Plc ? TradeIdeas via https://t.co/VS8RO1bzXJ to FREE Trading Room June 7th 2019, 2:06pm |
 |
@AlertTrade TREND REVERSAL UP ALERT: $JAZZ Jazz Pharmaceuticals Plc ? TradeIdeas via https://t.co/VS8RO1bzXJ to FREE Trading Room June 7th 2019, 2:06pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.